From The Breach: “Once a vibrant grassroots social movement, patient groups in Canada have become a powerful cluster of corporate-influenced organizations, with leaders whose values, beliefs and ties align more closely with the private sector than the public interest.
For over two decades, aided by the same public relations firms that work for pharmaceutical companies, these industry-funded patient groups in Canada have brought the full weight of lobby tactics to bear on the government and the country’s drug agencies.
Patients critical of industry have been sidelined and patient communities divided, while an elite group of leaders—many with no direct experience with the serious diseases their groups represent—earn six-figure salaries and wield significant influence shaping policies that reverberate through the healthcare system.
Understanding this transformation—how patient groups were co-opted into fighting affordable medicine—is crucial to understanding the incredible grip that pharmaceutical companies have over government policy today.”
Back to Around the Web